Versant Ventures V (Canada), L.P.'s Net Worth
$0
Estimate Recalculated Jun 10, 2025 04:31PM EST
Who is Versant Ventures V (Canada), L.P.?
Versant Ventures V (Canada), L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Repare Therapeutics Inc., Crinetics Pharmaceuticals, Inc., Aprea Therapeutics, Inc., and CRISPR Therapeutics AG.
SEC CIK
Versant Ventures V (Canada), L.P.'s CIK is 0001716490
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.33% | -2.30M |
—
|
—
| 4.61M |
Sep 5
| |||
| No matching records found | |||||||||
Turnstone Biologics Corp. (TSBX) Snapshot price: $0.5884
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.38M |
$12.00 |
—
| 3.38M |
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.54% | -1.45M |
$12.25 | -$9,188,775.00 | 4.98M |
Jun 3 - Jun 6
| |||
Form 4
| -39.68% | -152.07K |
—
|
—
| 231.21K |
Scheduled
|
Aug 5
| ||
Form 4
| -16.37% | -75.00K |
—
|
—
| 383.28K |
Jun 1
| |||
Form 4
| -9.99% | -240.75K |
—
|
—
| 2.17M |
Scheduled
|
May 5
| ||
Form 4
| -10.29% | -350.00K |
—
|
—
| 3.05M |
Scheduled
|
Feb 16
| ||
Form 4
| -9.36% | -600.00K |
—
|
—
| 5.81M |
Scheduled
|
Jan 29
| ||
Form 4
| -7.23% | -500.00K |
—
|
—
| 6.41M |
Scheduled
|
Jan 14
| ||
Form 4
| -10.12% | -325.00K |
—
|
—
| 2.88M |
Scheduled
|
Dec 15
| ||
Form 4
| +64.65% | 6.5M |
$20.00 | $5,000,000.00 | 16.54M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.00% | -507.59K |
—
|
—
| 2.88M |
Feb 4
| |||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.50% | -881.76K |
—
|
—
| 4.16M |
Apr 9 - May 18
| |||
Form 4
| +22,415.04% | 2.84M |
$15.00 | $4,999,995.00 | 2.85M |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||